|
|
||||||||
Basic Science Investigations |
Department of Nuclear Medicine, Laboratory of Molecular Imaging, Friedrich-Alexander University, Erlangen, Germany
The contribution of 18F-FDG uptake by endothelial cells to uptake values measured by PET in various tissues is as yet unclear. We therefore sought to characterize 18F-FDG uptake in an in vitro model of human endothelial cells. Methods: Commercially obtained human umbilical vein endothelial cells (HUVECs) were seeded in 6-multiwell plates 4896 h before incubation with 12 MBq 18F-FDG per well. Radioactivity measurements were performed after washing and mechanical dissolvation of the cellular monolayers. Cellular 18F-FDG uptake was referred to protein concentration. This experimental protocol was subsequently varied to study the effect of different parameters of interest. Furthermore, radio-thin-layer chromatography was used to identify intracellular 18F-FDG metabolites. 18F-FDG uptake in HUVECs was compared with that by a human monocytemacrophage (HMM) preparation and by glioblastoma cells (GLIOs) under identical experimental conditions. Results: 18F-FDG accumulated in HUVECs in a time-dependent manner and was trapped mainly as 18F-FDG-6-phosphate and 18F-FDG-1,6-diphosphate. Unlabeled glucose and cytochalasin B competitively inhibited 18F-FDG uptake, whereas phlorizin had no significant effect. Glucose deprivation significantly enhanced 18F-FDG uptake by a factor of 2.7, whereas sodium depletion had no significant influence. HUVECs treated with vascular endothelial growth factor (VEGF) showed a significant 82% increase in 18F-FDG accumulation after a 2-h exposure to 50 ng/mL VEGF. 18F-FDG uptake in HUVECs was significantly higher than that in HMMs and in the range of the uptake values measured in GLIOs. Conclusion: 18F-FDG accumulates in HUVECs by mechanisms analogous to those in neoplastic cells or neurons. VEGF significantly stimulates endothelial 18F-FDG uptake. The observed differences in 18F-FDG uptake between HUVECs, HMMs, and GLIOs are difficult to extrapolate to in vivo conditions but stimulate further studies on the contribution of endothelial 18F-FDG uptake to the overall uptake of that tracer in neoplastic or vascular lesions.
Key Words: 18F-FDG glucose transport endothelium human umbilical vein endothelial cells vascular endothelial growth factor
This article has been cited by other articles:
![]() |
D. Blaser, S. Maschauer, T. Kuwert, and O. Prante In Vitro Studies on the Signal Transduction of Thyroidal Uptake of 18F-FDG and 131I-Iodide J. Nucl. Med., August 1, 2006; 47(8): 1382 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Shankar, J. M. Hoffman, S. Bacharach, M. M. Graham, J. Karp, A. A. Lammertsma, S. Larson, D. A. Mankoff, B. A. Siegel, A. Van den Abbeele, et al. Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials J. Nucl. Med., June 1, 2006; 47(6): 1059 - 1066. [Full Text] [PDF] |
||||
![]() |
M. M. Abouzied, E. S. Crawford, and H. A. Nabi 18F-FDG Imaging: Pitfalls and Artifacts J. Nucl. Med. Technol., September 1, 2005; 33(3): 145 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Paik, K.-H. Lee, B.-H. Ko, Y. S. Choe, Y. Choi, and B.-T. Kim Nitric Oxide Stimulates 18F-FDG Uptake in Human Endothelial Cells Through Increased Hexokinase Activity and GLUT1 Expression J. Nucl. Med., February 1, 2005; 46(2): 365 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Buck and S. N. Reske Cellular Origin and Molecular Mechanisms of 18F-FDG Uptake: Is There a Contribution of the Endothelium? J. Nucl. Med., March 1, 2004; 45(3): 461 - 463. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |